AKT1 and metabolic dysfunction-associated steatotic liver disease: Accumulating evidence indicates that dysregulation of the PI3K/AKT pathway in hepatocytes is a common molecular event associated with metabolic dysfunctions including the NAFLD and the pathogenesis of insulin resistance.